Covered recipient · General Payments record
AMANDA ROSE HENRY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$181.68
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $166.95 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $73.71 | 4 |
| Actelion Pharmaceuticals US, Inc. | $23.21 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.85 | 1 |
| DEXCOM, INC. | $17.48 | 1 |
| Acerta Pharma LLC | $15.40 | 1 |
| Janssen Pharmaceuticals, Inc | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $23.21 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174241942 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.40 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206451546 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.85 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222932158 | CMS |
| Dexcom, Inc. | $17.48 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250468193 | CMS |
| Janssen Pharmaceuticals, Inc | $14.30 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174575502 | CMS |
| Novo Nordisk Inc | $16.64 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188450480 | CMS |
| Novo Nordisk Inc | $16.64 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188912982 | CMS |
| Novo Nordisk Inc | $17.63 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188962990 | CMS |
| Novo Nordisk Inc | $22.80 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188539460 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.